Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Evens, Andrew M  [Clear All Filters]
2024
Sullivan MR, White RP, Kanetkar N, Fridman IBerger, Ekenseair A, Evens AM, Konry T. Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model. Cell Death Dis. 2024;15(1):18.
Parsons SK, Rodday AMae, Upshaw JN, Scharman CD, Cui Z, Cao Y, Tiger YKyoung Ryu, Maurer MJ, Evens AM. Harnessing multi-source data for individualized care in Hodgkin Lymphoma. Blood Rev. 2024:101170.
2023
David KA, Sundaram S, Kim S-H, Vaca R, Lin Y, Singer S, Malecek M-K, Carter J, Zayac A, Kim MSun, et al. Older Patients with Primary Central Nervous System Lymphoma: Survival and Prognostication Across 20 US Cancer Centers. Am J Hematol. 2023.
Desai SH, Spinner MA, Evens AM, Sýkorová A, Bachanova V, Goyal G, Kahl BS, Dorritie KA, Azzi J, Kenkre VP, et al. Overall survival of cHL patients who progress after autologous stem cell transplant: results in novel agent era. Blood Adv. 2023.
2019
Paudel N, Schulze D, Gentzler RD, Evens AM, Helenowski I, Dillehay G, Frankfurt O, Mehta J, Donnelly ED, Gordon LI, et al. Patterns of Failure and Survival Outcomes After Total Lymphoid Irradiation and High-Dose Chemotherapy With Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2019.
2014
Kostakoglu L, Evens AM. FDG-PET Imaging for Hodgkin Lymphoma: Current Use and Future Applications. Clin Adv Hematol Oncol. 2014;12(1):20-35.